REFERENCES
1. World Health Organization. WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Available from https://www.who.int/publications/i/item/9789240093461. [accessed 4 November 2026].
2. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199-226.
3. World Health Organization. Vaccines could avert half a million deaths associated with anti-microbial resistance a year. Available from https://www.who.int/news/item/28-07-2023-vaccines-could-avert-half-a-million-deaths-associated-with-anti-microbial-resistance-a-year. [accessed 4 November 2026].
4. Miethke M, Pieroni M, Weber T, et al. Towards the sustainable discovery and development of new antibiotics. Nat Rev Chem. 2021;5:726-49.
5. Anderson AS. Vaccines against antimicrobial resistance. Philos Trans R Soc Lond B Biol Sci. 2026;381:20250007.
6. Darby EM, Trampari E, Siasat P, et al. Author correction: molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2024;22:255.
7. Jiang B, Lai Y, Xiao W, et al. Microbial extracellular vesicles contribute to antimicrobial resistance. PLoS Pathog. 2024;20:e1012143.
8. GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022;400:2221-48. Available from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02185-7/fulltext. [accessed 4 November 2026].
9. Hu J, Xie Y, Guan W, Huang L, Li X. Klebsiella pneumoniae vaccines: Evolving the blueprint from traditional platforms to mucosal and nanoscale delivery. Mater Today Bio. 2026;37:102919.
10. Briles DE, Paton JC, Mukerji R, Swiatlo E, Crain MJ. Pneumococcal vaccines. Microbiol Spectr. 2019;7:20.
11. Li S, Liang H, Zhao SH, Yang XY, Guo Z. Recent progress in pneumococcal protein vaccines. Front Immunol. 2023;14:1278346.
12. Ñahui Palomino RA, Vanpouille C, Costantini PE, Margolis L. Microbiota-host communications: bacterial extracellular vesicles as a common language. PLoS Pathog. 2021;17:e1009508.
13. Battista M, Saffer C, Figge MT, Vilhena C. Mechanistic insights into the role of extracellular vesicles at the bacterial-host interface. ACS Infect Dis. 2025;11:3407-13.
14. da Luz BSR, de Rezende Rodovalho V, Nicolas A, et al. Impact of environmental conditions on the protein content of staphylococcus aureus and its derived extracellular vesicles. Microorganisms. 2022;10:1808.
15. Battista M, Bachelot Y, Franke T, et al. Environmental cues shape extracellular vesicles biogenesis and function in Streptococcus pneumoniae. BMC Microbiol. 2026;26:320.
16. Briaud P, Frey A, Marino EC, et al. Temperature influences the composition and cytotoxicity of extracellular vesicles in Staphylococcus aureus. mSphere. 2021;6:e0067621.
17. Toyofuku M, Schild S, Kaparakis-Liaskos M, Eberl L. Composition and functions of bacterial membrane vesicles. Nat Rev Microbiol. 2023;21:415-30.
18. Moghaddam ZS, Dehghan A, Halimi S, et al. Bacterial extracellular vesicles: bridging pathogen biology and therapeutic innovation. Acta Biomater. 2025;200:1-20.
19. Rocha Minarini LAD. Exploring bacterial extracellular vesicles: focus on WHO critical priority pathogens. Curr Top Membr. 2024;94:225-46.
20. Lei TY, Liao BB, Yang LR, Wang Y, Chen XB. Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: a global public health threat. Microbiol Res. 2024;288:127839.
21. Li L, Xu X, Cheng P, et al. Klebsiella pneumoniae derived outer membrane vesicles mediated bacterial virulence, antibiotic resistance, host immune responses and clinical applications. Virulence. 2025;16:2449722.
22. Song HW, Lin Y, Wan TE, et al. Global burden of Klebsiella pneumoniae infections and antimicrobial resistance in 2019. BMC Infect Dis. 2025;25:1773.
23. Fan F, Chen G, Deng S, Wei L. Proteomic analysis of meropenem-induced outer membrane vesicles released by carbapenem-resistant Klebsiella pneumoniae. Microbiol Spectr. 2024;12:e0291723.
24. Fan F, Wang J, Chen H, Wei L, Zhang Z. Isolation and protein MdtQ analysis of outer membrane vesicles released by carbapenem-resistant Klebsiella pneumoniae. Microb Pathog. 2023;183:106325.
25. Li P, Luo W, Xiang TX, et al. Horizontal gene transfer via OMVs co-carrying virulence and antimicrobial-resistant genes is a novel way for the dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2022;13:945972.
26. Tang B, Yang A, Liu P, et al. Outer membrane vesicles transmitting blaNDM-1 mediate the emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Antimicrob Agents Chemother. 2023;67:e0144422.
27. Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 2015;15:375-87.
28. Charpentier LA, Dolben EF, Hendricks MR, Hogan DA, Bomberger JM, Stanton BA. Bacterial outer membrane vesicles and immune modulation of the host. Membranes. 2023;13:752.
29. Li P, Peng T, Xiang T, et al. Klebsiella pneumoniae outer membrane vesicles induce strong IL-8 expression via NF-κB activation in normal pulmonary bronchial cells. Int Immunopharmacol. 2023;121:110352.
30. Ye C, Li W, Yang Y, et al. Inappropriate use of antibiotics exacerbates inflammation through OMV-induced pyroptosis in MDR Klebsiella pneumoniae infection. Cell Rep. 2021;36:109750.
31. Martora F, Pinto F, Folliero V, et al. Isolation, characterization and analysis of pro-inflammatory potential of Klebsiella pneumoniae outer membrane vesicles. Microb Pathog. 2019;136:103719.
32. Assoni L, Girardello R, Converso TR, Darrieux M. Current stage in the development of Klebsiella pneumoniae vaccines. Infect Dis Ther. 2021;10:2157-75.
33. Li W, Hu Y, Zhang Q, et al. Development of drug-resistant Klebsiella pneumoniae vaccine via novel vesicle production technology. ACS Appl Mater Interfaces. 2021;13:32703-15.
34. Wu G, Ji H, Guo X, et al. Nanoparticle reinforced bacterial outer-membrane vesicles effectively prevent fatal infection of carbapenem-resistant Klebsiella pneumoniae. Nanomedicine. 2020;24:102148.
35. Parsons JB, Mourad A, Conlon BP, Kielian T, Fowler VG Jr. Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment. Nat Rev Microbiol. 2026;24:127-45.
36. Fu C, Li Z, Sun Y, Lin S, Yang X, Li X. Advances in Staphylococcus aureus extracellular vesicles: navigating challenges, embracing prospects. Lett Appl Microbiol. 2026;79:ovag009.
37. Liu ZH, Wu QY, Xu F, Zhang X, Liao XB. Biofunction and clinical potential of extracellular vesicles from methicillin-resistant Staphylococcus aureus. Microbiol Res. 2023;266:127238.
38. Kim SW, Seo JS, Park SB, et al. Significant increase in the secretion of extracellular vesicles and antibiotics resistance from methicillin-resistant Staphylococcus aureus induced by ampicillin stress. Sci Rep. 2020;10:21066.
39. Lee AR, Park SB, Kim SW, et al. Membrane vesicles from antibiotic-resistant Staphylococcus aureus transfer antibiotic-resistance to antibiotic-susceptible Escherichia coli. J Appl Microbiol. 2022;132:2746-59.
40. Kengmo Tchoupa A, Peschel A. Staphylococcus aureus releases proinflammatory membrane vesicles to resist antimicrobial fatty acids. mSphere. 2020;5:e00804-20.
41. Asano K, Hirose S, Narita K, et al. Extracellular vesicles from methicillin resistant Staphylococcus aureus stimulate proinflammatory cytokine production and trigger IgE-mediated hypersensitivity. Emerg Microbes Infect. 2021;10:2000-9.
42. Torrealba MP, Yoshikawa FSY, Aoki V, Sato MN, Orfali RL. State of the art on the role of Staphylococcus aureus extracellular vesicles in the pathogenesis of atopic dermatitis. Microorganisms. 2024;12:531.
43. Chen X, Zhang J, Yang M, Du G, Chen F. Methicillin-resistant Staphylococcus aureus membrane vesicles inhibit the proliferation and induce the apoptosis of epithelial cells. Pathogens. 2022;11:1429.
44. Wang X, Thompson CD, Weidenmaier C, Lee JC. Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform. Nat Commun. 2018;9:1379.
45. Chen G, Bai Y, Li Z, Wang F, Fan X, Zhou X. Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways. Theranostics. 2020;10:7131-49.
46. Li L, Ma J, Yu Z, Li M, Zhang W, Sun H. Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: an updated review. Microbiol Res. 2023;266:127221.
47. Parveen S, Subramanian K. Emerging roles of extracellular vesicles in pneumococcal infections: immunomodulators to potential novel vaccine candidates. Front Cell Infect Microbiol. 2022;12:836070.
48. Guo J, Huang Z, Wang Q, et al. Opportunities and challenges of bacterial extracellular vesicles in regenerative medicine. J Nanobiotechnology. 2025;23:4.
49. Werner Lass S, Smith BE, Camphire S, et al. Pneumococcal extracellular vesicles mediate horizontal gene transfer via the transformation machinery. mSphere. 2024;9:e0072724.
50. Cui L, Yang R, Huo D, et al. Streptococcus pneumoniae extracellular vesicles aggravate alveolar epithelial barrier disruption via autophagic degradation of OCLN (occludin). Autophagy. 2024;20:1577-96.
51. Battista M, Hoffmann B, Bachelot Y, et al. The role of pneumococcal extracellular vesicles on the pathophysiology of the kidney disease hemolytic uremic syndrome. mSphere. 2023;8:e0014223.
52. Ozisik L. The new era of pneumococcal vaccination in adults: what is next? Vaccines 2025;13:498.
53. Dookie R, Narciso AR, Gaytán MO, et al. Pneumococcal membrane particles promote serotype-independent cellular and humoral immunity and protect against pneumococcal colonization. Proc Natl Acad Sci U S A. 2026;123:e2537226123.
54. Carneiro GB, Yerneni SS, Chinaia K, et al. Protection induced by Streptococcus pneumoniae extracellular vesicles against nasal colonization and invasive infection in mice and the role of PspA. Vaccine. 2025;44:126566.
55. Mehanny M, Boese A, Bornamehr B, et al. Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization. Int J Pharm. 2022;621:121794.
56. De Langhe N, Van Dorpe S, Guilbert N, et al. Mapping bacterial extracellular vesicle research: insights, best practices and knowledge gaps. Nat Commun. 2024;15:9410.
57. Welsh JA, Goberdhan DCI, O’Driscoll L, et al. ; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
58. Gu Z, Unitt A, Harrison OB, et al. Gonococcal outer membrane vesicle vaccines: bacterial population biology, clinical trials, immune profiling, and vaccine design. NPJ Vaccines. 2026;11:85.
